Optimising clinical trial design choices in inflammatory bowel disease

Peter Bossuyt, Katarzyna Moscicka, Kremena Stoyanova, Jennifer Zalud, Luke M Shelton

Open source

DOI
10.1136/bmjgast-2026-002489
Published
2026-09
Container
BMJ Open Gastroenterology
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjgast-2026-002489,
  title = {Optimising clinical trial design choices in inflammatory bowel disease},
  author = {Peter Bossuyt and Katarzyna Moscicka and Kremena Stoyanova and Jennifer Zalud and Luke M Shelton},
  year = {2026},
  journal = {BMJ Open Gastroenterology},
  doi = {10.1136/bmjgast-2026-002489},
  url = {https://doi.org/10.1136/bmjgast-2026-002489}
}

RIS

TY  - JOUR
TI  - Optimising clinical trial design choices in inflammatory bowel disease
AU  - Peter Bossuyt
AU  - Katarzyna Moscicka
AU  - Kremena Stoyanova
AU  - Jennifer Zalud
AU  - Luke M Shelton
PY  - 2026
JO  - BMJ Open Gastroenterology
DO  - 10.1136/bmjgast-2026-002489
UR  - https://doi.org/10.1136/bmjgast-2026-002489
ER  - 

APA

Bossuyt, P., Moscicka, K., Stoyanova, K., Zalud, J., & Shelton, L. M. (2026). Optimising clinical trial design choices in inflammatory bowel disease. BMJ Open Gastroenterology. https://doi.org/10.1136/bmjgast-2026-002489

Source records